Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
Dig Endosc. 2022 Mar;34(3):604-611. doi: 10.1111/den.14097. Epub 2021 Aug 16.
Hepaticojejunostomy anastomotic stricture (HJAS) is a significant complication of biliary reconstruction surgery. Endoscopic management of HJAS using double-balloon enteroscopy has expanded; however, retrospective reports in this setting are limited. This study aimed to evaluate the efficacy of endoscopic balloon dilatation combined with stent deployment for HJAS.
This was a single-arm prospective clinical trial involving 40 patients with treatment-naïve HJAS enrolled between March 2016 and August 2019 at four endoscopy units in Japan. For HJAS, plastic stents combined with balloon dilatation were placed for 6 months after initial stenting. The primary outcome was HJ anastomosis patency 12 months after stent removal.
The technical success rate was 97.5% (39/40). The failed case required percutaneous transhepatic biliary drainage using the rendezvous technique. All cases achieved successful endoscopic treatment. During the treatment period, four of 40 patients (10%) ended the study protocol due to unrelated causes and were excluded from the primary analysis. Among the 36 patients, clinical success was achieved in 34 (94.4%) patients. The remaining two patients achieved HJAS resolution after an additional 3 months. All 36 patients achieved HJAS resolution. Adverse events were observed in two patients (5.0%) who developed moderate cholangitis. During a median follow-up of 21.3 months, HJAS recurrence was observed in 8.3% (3/36) with a median time to recurrence of 4.3 months and HJ anastomosis patency at 12 months was 94.4%.
Endoscopic balloon dilatation combined with plastic stent deployment for 6 months was a safe and effective strategy for HJAS. (Clinical Trial Registry no. UMIN000020613).
胆肠吻合口狭窄(HJAS)是胆道重建手术后的一种严重并发症。使用双气囊小肠镜进行内镜下 HJAS 治疗的方法已经得到了扩展;然而,在这种情况下,回顾性报告是有限的。本研究旨在评估内镜下球囊扩张联合支架置入治疗 HJAS 的疗效。
这是一项单臂前瞻性临床试验,纳入了 2016 年 3 月至 2019 年 8 月在日本四个内镜中心的 40 例初次治疗的 HJAS 患者。对于 HJAS,在初次放置支架后 6 个月内,联合使用塑料支架和球囊扩张进行治疗。主要结局是支架取出后 12 个月时 HJ 吻合口通畅。
技术成功率为 97.5%(39/40)。失败的病例需要采用经皮经肝胆管引流联合会师技术。所有病例均成功进行了内镜治疗。在治疗期间,由于其他原因,40 例患者中有 4 例(10%)终止了研究方案,并被排除在主要分析之外。在 36 例患者中,34 例(94.4%)患者达到了临床成功。其余 2 例患者在额外 3 个月后 HJAS 得到解决。所有 36 例患者的 HJAS 均得到解决。有 2 例患者(5.0%)出现中度胆管炎,观察到不良事件。在中位随访 21.3 个月期间,8.3%(3/36)的患者出现 HJAS 复发,复发时间的中位数为 4.3 个月,12 个月时 HJ 吻合口通畅率为 94.4%。
内镜下球囊扩张联合塑料支架置入 6 个月是治疗 HJAS 的一种安全有效的策略。(临床试验注册号:UMIN000020613)。